Oxathiazin_dioxide for treating, preventing, inhibiting or reducing cytokine release
Номер патента: EP3972609A1
Опубликовано: 30-03-2022
Автор(ы): Hanns Moehler, James C. Costin, Thomas Mueller
Принадлежит: Geistlich Pharma AG
Опубликовано: 30-03-2022
Автор(ы): Hanns Moehler, James C. Costin, Thomas Mueller
Принадлежит: Geistlich Pharma AG
Реферат: A method of preventing, inhibiting or reducing cytokine release and the incidence of a cytokine release syndrome (CRS) or a cytokine storm in a subject with certain oxathiazin-like compounds and/or related compounds.
Oxathiazin_dioxide for treating, preventing, inhibiting or reducing cytokine release
Номер патента: CA3141035C. Автор: Thomas Mueller,James C. Costin,Hanns Moehler. Владелец: Geistlich Pharma AG. Дата публикации: 2023-12-19.